NO984189D0 - Procedure for the treatment of bipolar disorder - Google Patents

Procedure for the treatment of bipolar disorder

Info

Publication number
NO984189D0
NO984189D0 NO984189A NO984189A NO984189D0 NO 984189 D0 NO984189 D0 NO 984189D0 NO 984189 A NO984189 A NO 984189A NO 984189 A NO984189 A NO 984189A NO 984189 D0 NO984189 D0 NO 984189D0
Authority
NO
Norway
Prior art keywords
procedure
treatment
bipolar disorder
bipolar
disorder
Prior art date
Application number
NO984189A
Other languages
Norwegian (no)
Other versions
NO984189L (en
Inventor
Jr Charles M Beasley
Gary D Tollefson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO984189D0 publication Critical patent/NO984189D0/en
Publication of NO984189L publication Critical patent/NO984189L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
NO984189A 1996-03-11 1998-09-11 Procedure for the treatment of bipolar disorder NO984189L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1315996P 1996-03-11 1996-03-11
PCT/US1996/019575 WO1997033577A1 (en) 1996-03-11 1996-12-04 Method for treating bipolar disorder

Publications (2)

Publication Number Publication Date
NO984189D0 true NO984189D0 (en) 1998-09-11
NO984189L NO984189L (en) 1998-09-11

Family

ID=21758606

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984189A NO984189L (en) 1996-03-11 1998-09-11 Procedure for the treatment of bipolar disorder

Country Status (15)

Country Link
EP (1) EP0889725A4 (en)
JP (1) JP2000506859A (en)
KR (1) KR19990087713A (en)
CN (1) CN1213966A (en)
AU (1) AU734011B2 (en)
BR (1) BR9612548A (en)
CZ (1) CZ290298A3 (en)
EA (1) EA000758B1 (en)
HU (1) HUP9903679A3 (en)
IL (1) IL126162A0 (en)
NO (1) NO984189L (en)
NZ (1) NZ326031A (en)
PL (1) PL328925A1 (en)
TR (1) TR199801797T2 (en)
WO (1) WO1997033577A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960577B2 (en) 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
PL344331A1 (en) * 1998-05-22 2001-11-05 Lilly Co Eli Combination therapy for treatment of refractory depression
BR9911068A (en) * 1998-05-29 2001-02-06 Lilly Co Eli Combination therapy for the treatment of bipolar disorders
CA2351719A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. Pharmaceutical compositions containing olanzapine-n-oxide
EP1133299A1 (en) * 1998-11-23 2001-09-19 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
AU757973B2 (en) * 1998-11-23 2003-03-13 Sepracor, Inc. Desmethylolanzapine compositions and methods
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use

Also Published As

Publication number Publication date
TR199801797T2 (en) 1998-12-21
EA000758B1 (en) 2000-04-24
HUP9903679A2 (en) 2000-04-28
HUP9903679A3 (en) 2001-10-29
BR9612548A (en) 1999-07-20
NZ326031A (en) 2001-05-25
KR19990087713A (en) 1999-12-27
EA199800819A1 (en) 1999-02-25
CN1213966A (en) 1999-04-14
EP0889725A4 (en) 2000-01-19
AU1330797A (en) 1997-10-01
AU734011B2 (en) 2001-05-31
NO984189L (en) 1998-09-11
JP2000506859A (en) 2000-06-06
PL328925A1 (en) 1999-03-01
EP0889725A1 (en) 1999-01-13
IL126162A0 (en) 1999-05-09
CZ290298A3 (en) 1999-10-13
WO1997033577A1 (en) 1997-09-18

Similar Documents

Publication Publication Date Title
NO984431D0 (en) Procedure for treating pain
NO991955D0 (en) Process for the treatment of hydrocarbons
NO991381L (en) Combination therapy for the treatment of psychoses
NO20005864D0 (en) Quinasols for the treatment of brain tumor
NO20005884D0 (en) Combination therapy for the treatment of bipolar disorders
NO983284D0 (en) Anticoagulants suitable for the treatment of thrombosis
NO983266D0 (en) Distributed Treatment
FI971568A (en) Procedure for the treatment of resistant tumors
NO976063D0 (en) Procedure for the treatment of diabetes
NO990722D0 (en) Procedure for the treatment of heart failure
DK0752870T3 (en) Use of Mycobacterium for the treatment of tumors
ATE347372T1 (en) VACCINES FOR THE TREATMENT OF MYCOSIS
FI964572A0 (en) Process for the preparation of homopolymers or copolymers of propyleneProcess for the preparation of homopolymers or copolymers of propylene
NO984446D0 (en) Procedure for treating pain
NO983263L (en) Distributed treatment
ATE226071T1 (en) ANTICONVULSIVE DERIVATIVES FOR THE TREATMENT OF NEUROPATHIC PAIN
NO984432L (en) Procedure for the treatment of migraine pain
IS4789A (en) treatment Compounds
NO991460L (en) Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
NO984189D0 (en) Procedure for the treatment of bipolar disorder
NO991734D0 (en) Pyrazolinones for the treatment of potency disorders
DE69834937D1 (en) ANTIBIOTICS FOR THE TREATMENT OF STOMACHES
NO973366D0 (en) Procedure for the treatment of multiple sclerosis
NO20003481D0 (en) Procedure for the treatment of COPD
NO991158D0 (en) Procedure for the treatment of amyotrophic lateral sclerosis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application